glp 1 incretin mimetics PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Incretins GLP-1 actions and target organs.

Neuroimaging evidence supports central modulation of food reward, demonstrating reduced activation in reward-related brain regions such as the putamen and amygdala following exenatide administration [39]

However, Lipovite is not designed to replace GLP-1s but rather to support weight loss by increasing fat metabolism, enhancing liver health, and improving energy and mental clarity

Glucagon-like peptide-1 (GLP-1) receptor agonists aka the -tides, GLP analogs, incretin mimetics *The FDA has approved the use of -glutides to reduce the risk of major cardiovascular events (myocardial infarction, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors

10.2903/j.efsa.2021.6893 255